| Literature DB >> 27996035 |
Sudjit Luanpitpong1,2, Liying Wang3, Vincent Castranova2, Cerasela Zoica Dinu4, Surapol Issaragrisil1, Yi Charlie Chen5, Yon Rojanasakul2,6.
Abstract
class="Disease">Tumor microenv<class="Chemical">span class="Chemical">ironment has been recognized as a key determinant of tumor formation and metastasis, but how tumor microenvironment is affected by nanomaterials is essentially unknown. Here, we investigated whether carbon nanotubes (CNTs), a widely used nanomaterial with known carcinogenic potential, can affect cancer-associated fibroblasts (CAFs), which are a key component of tumor microenvironment that provides necessary support for tumor growth. We show for the first time that single-walled CNT and to a lesser extent multi-walled and its COOH-functionalized form induced CAF-like cells, which are non-tumorigenic in animals, but promote tumor growth of human lung carcinoma and CNT-transformed lung epithelial cells. The mechanism by which CNT-induced CAF-like cells promote tumor growth involved the acquisition of cancer stem cells (CSCs) in cancer population. Gene knockdown experiments showed that an expression of podoplanin on CAF-like cells is essential for their effects, indicating the functional role of CAF-like cells and podoplanin in CNT tumorigenic process. Our findings unveil a novel mechanism of CNT-induced carcinogenesis through the induction of CAF-like cells that support CSCs and drive tumor formation. Our results also suggest the potential utility of podoplanin as a mechanism-based biomarker for rapid screening of carcinogenicity of CNTs and related nanomaterials for their safer design.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27996035 PMCID: PMC5172236 DOI: 10.1038/srep39558
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Physicochemical properties of carbon nanotubes used in this study.
| SWCNT | MWCNT | f-MWCNT | |
|---|---|---|---|
| Source | Cheap Tubes Inc. | Cheap Tubes Inc. | Cheap Tubes Inc. |
| Catalog reference | SKU 0111 | SKU 030111 | SKU 030113 |
| Synthesis method | CCVD | CCVD | CCVD |
| Primary functionality | Pristine | Pristine | COOH (1.8%) |
| Dry mean width (nm) | 1–2 | 13–18 | 13–18 |
| Dry mean length (μm) | 5–30 | 1–12 | 1–12 |
| % elemental carbon | >95% | >95% | >95% |
| % iron impurity | 0.12% | Not detectable | N/A |
| Other metal impurities | Cr 0.31% | Ni 1.88% | N/A |
| Co 0.1% | Al 0.04% | ||
| Si 0.08% | Si 0.03% | ||
| SSA (m2/g) | >407 | >233 | >233 |
| Zeta potential (mV) | −7.44 | −9.58 | −8.66 |
aData from manufacturer’s datasheet.
bData from in-house analysis using energy dispersive X-ray spectroscopy (EDX-S).
cData from in-house analysis using Nano Series ZetaSizer. CCVD, plasma purified catalytic chemical vapor deposition. SSA, specific surface area.
Figure 1Carbon nanotubes induce transformation of primary human lung fibroblasts into cancer-associated fibroblasts.
Subconfluent monolayers of human lung fibroblasts were treated with various concentrations (0–0.15 μg/cm2) of SWCNT, MWCNT, or f-MWCNT for 48 h. (A) Analysis of cell viability and proliferation using the WST-1 assay. (B) Western blot analysis of the cancer-associated fibroblast marker podoplanin (PDPN) and myofibroblast marker α-SMA. β-actin was used to confirm equal loading of the samples. Immunoblot signals were quantified by densitometry, and mean data from three independent experiments (one of which is shown here) were normalized to the results obtained in cells without CNT treatment (control). (C) Secreted TGF-β levels in the culture medium of CNT-treated lung fibroblasts as determined by ELISA. Data are mean ± SD (n = 3). *P < 0.05 vs. vehicle-treated control cells. #P < 0.05 vs SWCNT-treated cells.
Figure 2Carbon nanotube-induced cancer-associated fibroblast-like cells promote tumor formation of human lung carcinoma H460 cells.
(A) Schematic diagram depicting methodological steps of in vivo and in vitro co-culture experiments. (B) SWCNT-induced cancer-associated fibroblast-like cells (LF/SWCNT) or vehicle-treated fibroblasts (LF/BSA) at the dose of 6 × 105 cells were co-injected with luciferase-labeled H460 cells at the dose of 3 × 105 cells (2:1 ratio) into the left and right flanks of NSG mice. Tumor formation was monitored weekly by IVIS bioluminescence imaging. IVIS images of mice at day 0 and week 3 are shown. (C) Normalization of tumor bioluminescence signals at various time points post-injection to their initial signals at day 0. (D) Subcutaneous tumors were dissected from mice bearing H460 and LF/SWCNT or LF/BSA, and weighted at the end of experiments at 3 weeks post-injection. Data are mean ± SD (n = 4). *P < 0.05 vs H460 and LF/BSA group.
Figure 3Carbon nanotube-induced cancer-associated fibroblast-like cells promote the growth and maintenance of cancer stem cells.
Carbon nanotube-induced cancer-associated fibroblast-like cells (LF/SWCNT or LF/f-MWCNT) or vehicle-treated fibroblasts (LF/BSA) were co-cultured with GFP-labeled lung cancer H460 cells (2:1 ratio). (A) Analysis of soft agar colonies after 2 weeks of culture. Scale bar = 200 μm. (B) Analysis of tumor sphere formation after 2 weeks of culture. Scale bar = 300 μm. Data are mean ± SD (n = 4). *P < 0.05 vs H460 and LF/BSA group. #P < 0.05 vs H460 and LF/SWCNT group.
Figure 4Analysis of side population and lung stem cell marker CD133 in lung carcinoma cells cultured with carbon nanotube-induced cancer-associated fibroblast-like cells.
Carbon nanotube-induced cancer-associated fibroblast-like cells (LF/SWCNT or LF/f-MWCNT) or vehicle-treated fibroblasts (LF/BSA) were co-cultured with GFP-labeled lung cancer H460 cells (2:1 ratio). (A) Analysis of side population (SP) of the GFP-labeled H460 cells in the presence or absence of fumitremorgin c (FTC) using FACS. SP cells (box) are determined by their disappearance in the presence of FTC. (B) Western blot analysis of lung stem cell marker CD133 in the co-culture of H460 cells with LF/BSA, LF/SWCNT or LF/f-MWCNT cells.
Figure 5Carbon nanotube-induced cancer associated fibroblast-like cells are incapable of inducing cancer stem cells in the absence of podoplanin.
(A) Human lung fibroblasts were stably transfected with shRNA plasmid against podoplanin (shPDPN) or scramble control (shCON), and treated with SWCNT, MWCNT or f-MWCNT at the dose of 0.15 μg/cm2 for 48 h. Podoplanin level was detected by Western blotting. (B) Carbon nanotube-induced cancer-associated shCON fibroblast-like cells (shCON-LF/SWCNT or LF/f-MWCNT) or carbon nanotube-treated shPDPN fibroblast-like cells (shPDPN-LF/SWNCT or LF/f-MWCNT) were co-cultured with H460 cells (2:1 ratio), and tumor sphere formation was analyzed after 2 weeks of culture. Scale bar = 200 μm. Data are mean ± SD (n = 4). *P < 0.05 vs H460 and shCON-LF/BSA group. §P < 0.05 vs CNT-treated shCON group. #P < 0.05 vs shCON-LF/SWCNT group.
Figure 6Podoplanin is required for the tumor promoting effect of carbon nanotube-induced cancer-associated fibroblasts.
(A) Carbon nanotube-induced cancer-associated shCON fibroblast-like cells (shCON/SWCNT) or carbon nanotube-treated shPDPN fibroblast-like cells (shPDPN/SWCNT) at the dose of 6 × 105 cells were co-injected with luciferase-labeled H460 cells at the dose of 3 × 105 cells (2:1 ratio) into the left and right flanks of NSG mice. Tumor formation was monitored weekly by IVIS bioluminescence imaging. IVIS images of mice at day 0 and week 2 and 3 are shown. (B) Normalization of tumor bioluminescence signals at various time points post-injection to their initial signals at day 0. (C) Subcutaneous tumors were dissected from mice bearing H460 and LF/SWCNT or LF/BSA, and were weighted at the end of experiments at 3 weeks post-injection. Data are mean ± SD (n = 4). *P < 0.05 vs H460 and shCON/SWCNT group.
Figure 7Carbon nanotube-induced cancer-associated fibroblast-like cells and podoplanin level are associated with tumorigenicity of carbon nanotube-transformed cells.
(A) Carbon nanotube-induced cancer-associated shCON fibroblast-like cells (shCON-LF/SWCNT or LF/f-MWCNT) or carbon nanotube-treated shPDPN fibroblast-like cells (shPDPN-LF/SWCNT or LF/f-MWCNT) were co-cultured with SWCNT-transformed lung epithelial BEAS-2B/SWCNT cells (2:1 ratio), and tumor sphere formation was analyzed after 2 weeks of culture. Scale bar = 200 μm. (B) Carbon nanotube-induced cancer-associated fibroblast-like cells (LF/SWCNT) or vehicle-treated fibroblasts (LF/BSA) were co-injected with SWCNT-transformed lung epithelial BEAS-2B/SWNCT cells (2:1 ratio) into the left and right flanks of NSG mice. Tumor formation was monitored weekly by IVIS bioluminescence imaging. Normalization of tumor bioluminescence signals at various time points post-injection to their initial signals at day 0. (C) Subcutaneous tumors were dissected from mice bearing BEAS-2B/SWCNT and LF/SWCNT or LF/BSA, and were weighted at the end of experiments at 3 weeks post-injection. Data are mean ± SD (n = 4). *P < 0.05 vs H460 and shCON-LF/BSA group. §P < 0.05 vs CNT-treated shCON group. #P < 0.05 vs shCON-LF/SWCNT group.
Figure 8A schematic working model for the roles of carbon nanotubes in tumor promotion.
Carbon nanotubes can induce cancer associated fibroblast-like cells that promote cancer stem cell formation in lung epithelial cells.